🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the relative bioavailability (the ex...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT02390609
The purpose of this study is to test any good or bad effects of the study d...
Status
Completed
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2014-12-08
Trial ID
NCT02315326
Treatments Being Tested
This phase II trial studies how well ibrutinib, fludarabine phosphate, cycl...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2016-03-18
Trial ID
NCT02629809
Treatments Being Tested
Primary Objectives The primary objective of this study is to evaluate the e...
Status
Unknown
Location
Klinikum der Universität München
Start Date
2016-04
Trial ID
NCT02689869
The purpose of this study is to test the effects of a drug called Voraxaze ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2018-11-14
Trial ID
NCT03684980
Treatments Being Tested
This study is designed to determine the recommended phase 2 dose (RP2D), an...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2016-05-11
Trial ID
NCT02733042
Treatments Being Tested
The purpose of this study is to compare the effect of food and two modified...
Status
Completed
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT01820936
The goal of this clinical research study is to learn if blinatumomab can he...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2017-06-22
Trial ID
NCT03121534
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Terminated
Location
University of Arizona Cancer Center, Tucson
Start Date
2017-03-05
Trial ID
NCT02954406
Treatments Being Tested
This phase III trial studies ibrutinib and rituximab to see how well they w...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-03-10
Trial ID
NCT02048813